Publicacións en colaboración con investigadores/as de Stanford University School of Medicine (15)

2024

  1. GeNNius: an ultrafast drug-target interaction inference method based on graph neural networks

    Bioinformatics (Oxford, England), Vol. 40, Núm. 1

2023

  1. LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 6, pp. 1137-1154

  2. Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

    Nature Communications, Vol. 14, Núm. 1

2021

  1. Elevated NSD3 histone methylation activity drives squamous cell lung cancer

    Nature, Vol. 590, Núm. 7846, pp. 504-508

2020

  1. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

    Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1879-1895

2019

  1. Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma

    Nature Medicine, Vol. 25, Núm. 11, pp. 1783-1795

2017

  1. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Nature Communications, Vol. 8

2016

  1. The present and the future of the RAS pathway: From function and genomics to inhibition

    Cancer Biology and Therapy, Vol. 17, Núm. 7, pp. 719-722

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. A meta-Analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma

    Cancer Research, Vol. 74, Núm. 10, pp. 2892-2902

2012

  1. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo

    Cancer Research, Vol. 72, Núm. 22, pp. 5744-5756

  2. Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis

    PLoS Genetics, Vol. 8, Núm. 5

2011

  1. Tumor-stromal interactions of the bone microenvironment: In vitro findings and potential in vivo relevance in metastatic lung cancer models

    Clinical and Experimental Metastasis, Vol. 28, Núm. 8, pp. 779-791

2010

  1. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models

    Journal of Clinical Investigation, Vol. 120, Núm. 11, pp. 3940-3952

2008

  1. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism

    Cancer Research, Vol. 68, Núm. 7, pp. 2275-2285